310 related articles for article (PubMed ID: 18343059)
1. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.
Puglia C; Blasi P; Rizza L; Schoubben A; Bonina F; Rossi C; Ricci M
Int J Pharm; 2008 Jun; 357(1-2):295-304. PubMed ID: 18343059
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of percutaneous absorption of the repellent diethyltoluamide and the sunscreen ethylhexyl p-methoxycinnamate-loaded solid lipid nanoparticles: an in-vitro study.
Puglia C; Bonina F; Castelli F; Micieli D; Sarpietro MG
J Pharm Pharmacol; 2009 Aug; 61(8):1013-9. PubMed ID: 19703344
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
[TBL] [Abstract][Full Text] [Related]
6. Functional characterisation of novel analgesic product based on self-regulating drug carriers.
Cevc G; Vierl U; Mazgareanu S
Int J Pharm; 2008 Aug; 360(1-2):18-28. PubMed ID: 18524509
[TBL] [Abstract][Full Text] [Related]
7. Development of SLNs from natural lipids: application to topical delivery of tretinoin.
Mandawgade SD; Patravale VB
Int J Pharm; 2008 Nov; 363(1-2):132-8. PubMed ID: 18657601
[TBL] [Abstract][Full Text] [Related]
8. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2005 Jul; 298(1):55-67. PubMed ID: 15941634
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies.
Ricci M; Puglia C; Bonina F; Di Giovanni C; Giovagnoli S; Rossi C
J Pharm Sci; 2005 May; 94(5):1149-59. PubMed ID: 15793804
[TBL] [Abstract][Full Text] [Related]
11. Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: characterization and in vitro and in vivo evaluation.
Puglia C; Rizza L; Drechsler M; Bonina F
Drug Deliv; 2010 Apr; 17(3):123-9. PubMed ID: 20136625
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
14. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations.
Cevc G; Mazgareanu S; Rother M; Vierl U
Int J Pharm; 2008 Jul; 359(1-2):190-7. PubMed ID: 18499370
[TBL] [Abstract][Full Text] [Related]
15. Influence of solid lipid microparticle carriers on skin penetration of the sunscreen agent, 4-methylbenzylidene camphor.
Scalia S; Mezzena M; Iannuccelli V
J Pharm Pharmacol; 2007 Dec; 59(12):1621-7. PubMed ID: 18053323
[TBL] [Abstract][Full Text] [Related]
16. The role of vehicle-nanoparticle interactions in topical drug delivery.
Moddaresi M; Brown MB; Zhao Y; Tamburic S; Jones SA
Int J Pharm; 2010 Nov; 400(1-2):176-82. PubMed ID: 20727392
[TBL] [Abstract][Full Text] [Related]
17. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels.
Cevc G; Mazgareanu S; Rother M
Int J Pharm; 2008 Aug; 360(1-2):29-39. PubMed ID: 18337027
[TBL] [Abstract][Full Text] [Related]
18. [Comparative in vitro and in vivo studies on the permeation and penetration of ketoprofen and ibuprofen in human skin].
Bock U; Krause W; Otto J; Haltner E
Arzneimittelforschung; 2004; 54(9):522-9. PubMed ID: 15500198
[TBL] [Abstract][Full Text] [Related]
19. Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model.
Kuntsche J; Bunjes H; Fahr A; Pappinen S; Rönkkö S; Suhonen M; Urtti A
Int J Pharm; 2008 Apr; 354(1-2):180-95. PubMed ID: 17920216
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Antiinflammatory Effect of a Novel Gel System Containing Ketoprofen Solid Nanoparticles.
Nagai N; Iwamae A; Tanimoto S; Yoshioka C; Ito Y
Biol Pharm Bull; 2015; 38(12):1918-24. PubMed ID: 26632183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
